Envoy Medical (COCH) Income from Continuing Operations (2021 - 2026)
Envoy Medical (COCH) reported Income from Continuing Operations of 6223000.0 for Q1 2026, down 11.09% on a YoY basis from 6998844.81 in Q1 2025, and up 2.54% sequentially from 6385000.0 in Q4 2025.
Envoy Medical (COCH) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Envoy Medical (COCH) has 6 years of Income from Continuing Operations data on file, last reported at 6223000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 11.09% year-over-year to 6223000.0; the trailing twelve-month figure through Mar 2026 stood at 24481000.0 (up 98.75% YoY), and the FY2025 full-year result was 23860000.0, up 1.45% from the prior year.
- Income from Continuing Operations rose to 6223000.0 in Q1 2026, from 6385000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 12461381.0 in Q1 2022 to a low of 1855634000.0 in Q3 2024.
- A 5-year average of 115688696.06 and a median of 4933000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations jumped 1400.18% in 2022 and plunged 45325.56% in 2024, its largest moves.
- Tracing COCH's Income from Continuing Operations over 5 years: stood at 2008739.0 in 2022, then soared by 426.12% to 6551000.0 in 2023, then slumped by 175.3% to 4933000.0 in 2024, then retreated by 29.43% to 6385000.0 in 2025, then grew by 2.54% to 6223000.0 in 2026.
- Business Quant data shows COCH's Income from Continuing Operations at 6223000.0 in Q1 2026, 6385000.0 in Q4 2025, and 6179000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | -6.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.22 Mn |
| Dec 31, 2025 | -6.39 Mn |
| Sep 30, 2025 | -6.18 Mn |
| Jun 30, 2025 | -5.69 Mn |
| Mar 31, 2025 | -5.60 Mn |
| Dec 31, 2024 | -4.93 Mn |
| Sep 30, 2024 | -1.86 Bn |
| Jun 30, 2024 | -92.35 Mn |
| Mar 31, 2024 | -4.98 Mn |
| Dec 31, 2023 | 6.55 Mn |
| Sep 30, 2023 | -4.09 Mn |
| Jun 30, 2023 | -1.14 Mn |
| Mar 31, 2023 | 717,701.00 |
| Dec 31, 2022 | -2.01 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 12.46 Mn |
| Dec 31, 2021 | -4.72 Mn |
| Sep 30, 2021 | 5.57 Mn |
| Jun 30, 2021 | 371,144.00 |